共 50 条
The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia
被引:7
|作者:
Horvitz-Lennon, Marcela
[1
]
Predmore, Zachary
[1
,3
]
Orr, Patrick
[1
,5
]
Hanson, Mark
[2
,4
]
Hillestad, Richard
[2
]
Durkin, Mike
[6
]
El Khoury, Antoine C.
[6
]
Mattke, Soeren
[1
,4
]
机构:
[1] RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02116 USA
[2] RAND Corp, Santa Monica, CA USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Univ Southern Calif, Los Angeles, CA 90007 USA
[5] Informat Mapping, Boston, MA USA
[6] Janssen Sci Affairs LLC, Titusville, NJ USA
来源:
关键词:
Schizophrenia;
Treatment adherence;
Early detection;
Simulation;
QUALITY-OF-LIFE;
UNTREATED PSYCHOSIS;
1ST-EPISODE SCHIZOPHRENIA;
EARLY INTERVENTION;
NEGATIVE SYMPTOMS;
MENTAL-ILLNESS;
UNITED-STATES;
DURATION;
DISORDERS;
PEOPLE;
D O I:
10.1007/s10488-019-00990-7
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
The impact of initiatives aimed at reducing time in untreated psychosis during early-stage schizophrenia will be unknown for many years. Thus, we simulate the effect of earlier treatment entry and better antipsychotic drug adherence on schizophrenia-related hospitalizations, receipt of disability benefits, competitive employment, and independent/family living over a ten-year horizon. We predict that earlier treatment entry reduces hospitalizations by 12.6-14.4% and benefit receipt by 7.0-8.5%, while increasing independent/family living by 41.5-46% and employment by 42-58%. We predict larger gains if a pro-adherence intervention is also used. Our findings suggest substantial benefits of timely and consistent early schizophrenia care.
引用
收藏
页码:357 / 365
页数:9
相关论文